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Abstract. 
 
A member of the annexin XIII sub-family, 
annexin XIIIb, has been implicated in the apical exocy-
tosis of epithelial kidney cells. Annexins are phospho-
lipid-binding proteins that have been suggested to be 
involved in membrane trafficking events although their 
actual physiological function remains open. Unlike the 
other annexins, annexin XIIIs are myristoylated. Here, 
we show by immunoelectron microscopy that annexin 
XIIIb is localized to the 
 
trans
 
-Golgi network (TGN), 
vesicular carriers and the apical cell surface. Polarized 
apical sorting involves clustering of apical proteins into 
dynamic sphingolipid-cholesterol rafts. We now pro-
vide evidence for the raft association of annexin XIIIb. 
Using in vitro assays and either myristoylated or un-
myristoylated recombinant annexin XIIIb, we demon-
strate that annexin XIIIb in its native myristoylated 
form stimulates specifically apical transport whereas 
the unmyristoylated form inhibits this route. Moreover, 
we show that formation of apical carriers from the 
TGN is inhibited by an anti-annexin XIIIb antibody 
whereas it is stimulated by myristoylated recombinant 
annexin XIIIb. These results suggest that annexin
XIIIb directly participates in apical delivery.
Key words: cholesterol • exocytosis • MDCK • polar-
ity • raft
 
I
 
n
 
 the MDCK cell line sorting of apical and basolateral
proteins occurs in the TGN (Simons, 1995), from
where they are transported to their respective plasma
membrane domain (Rodriguez-Boulan and Nelson, 1989;
Simons and Ikonen, 1997; Weimbs et al., 1997).
Specific sorting determinants are required for polarized
targeting. An increasing body of evidence supports a hier-
archical read-out of the determinants.
For membrane proteins, basolateral sorting signals
which are dominant over apical ones have been identified
(Rodriguez-Boulan and Powell, 1992; Matter and Mell-
man, 1994). The basolateral signals include tyrosine- or
dileucine-based motifs similar to those implicated in clath-
rin-dependent endocytosis suggesting that these basolat-
eral proteins use similar mechanisms for recruitment into
vesicular carriers destined to the cell surface (Scheiffele
and Simons, 1998).
In the apical pathway, sorting of proteins can be con-
ferred by glycosylphosphatidylinositol (GPI)
 
1
 
 anchors, sig-
nals located in the transmembrane domain (Kundu et al.,
1996) and by glycosylation: N-glycosylation for membrane
proteins (Gut et al., 1998) and secreted proteins (Scheif-
fele et al., 1995) as well as O-glycosylation (Yeaman et al.,
1997). Not only proteins but also specific lipids e.g., gly-
cosphingolipids are apically targeted in epithelial cells
(van Meer, 1989). Analysis of the apical sorting of proteins
and lipids led to the raft hypothesis summarized by Simons
and Ikonen (1997). It proposes that dynamic lateral assem-
blies of sphingolipids and cholesterol subcompartimental-
ize membranes. Apical proteins are recruited into such mi-
crodomains from which basolateral proteins are excluded.
The exoplasmic sphingolipids possess long saturated fatty
acyl chains which allow them to form tightly packed as-
semblies within the more fluid environment of the kinked
 
cis
 
-unsaturated acyl chain phospholipids (e.g., phosphati-
dylcholine). Cholesterol, which is present in both leaflets,
plays an important role in stabilizing such lipid micro-
domains (Brown, 1998). Accumulating evidence suggests
that the sphingolipid-cholesterol rafts could constitute liq-
uid-ordered phases dispersed in the liquid-crystalline
phase formed within phosphatidylcholine enriched regions
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of cell membranes (Ahmed et al., 1997). The liquid-ordered
phase lipids can be isolated as detergent-insoluble gly-
cosphingolipid complexes (DIGs). After detergent extrac-
tion, the DIGs float when subjected to density gradient
centrifugation, facilitating their separation from the insol-
uble cytoskeleton-associated fraction (Brown and Rose,
1992). Apical transmembrane and GPI-anchored proteins
as well as some double acylated tyrosine kinases have
been isolated using this procedure demonstrating their
specific interaction with these lipid microdomains (Harder
and Simons, 1997; Scheiffele and Simons, 1998). More-
over, by in vitro
 
 
 
reconstitution experiments it has been
shown that detergent insolubility of the apical GPI-anchored
placental alkaline phosphatase depends on a raft lipid en-
vironment (Schroeder et al., 1994).
One objection that has been raised to the use of deter-
gent insolubility as a tool to detect lipid domains in cellu-
lar membranes is that detergent solubilization might cause
aggregation of membrane components that might not have
been in proximity in cell membranes. This could be due,
for instance, to the intrinsic insolubility of some lipids
(Schroeder et al., 1994) or to the coalescence of rafts upon
detergent extraction trapping proteins in close vicinity that
otherwise are not included into rafts. But, recently, evi-
dence obtained by several laboratories using different ap-
proaches excluded such a possibility (Brown and London,
1997). An additional criterion is to show that detergent in-
solubility depends on the integrity of raft domains by dis-
rupting them with methyl-
 
b
 
-cyclodextrin (Me
 
b
 
CD) which
extracts cholesterol from membranes (Klein et al., 1995;
Yancey et al., 1996). This treatment renders raft-associ-
ated proteins detergent soluble leading to a more stringent
definition for raft association, namely that raft association
is cholesterol-dependent (Harder and Simons, 1997). Two
results consistent with a role of rafts in apical membrane
trafficking were recently obtained (Keller and Simons,
1998). First, in cholesterol-depleted cells only apical trans-
port is impaired. Second, apically routed proteins are
mistargeted after cholesterol depletion probably due to
disorganization of rafts, interfering with apical protein
clustering (Cerneus et al., 1993; Hanada et al., 1995; Han-
nan and Edidin, 1996; Scheiffele et al., 1997). Therefore,
although rafts can also be found in the basolateral com-
partment (Melkonian et al., 1995), it is proposed that api-
cal proteins are recruited into large percolating raft do-
mains before apical carriers bud off the TGN. Another
example of such an assembly are caveolae that can be con-
sidered as a stable coalescence of rafts (Simons and
Ikonen, 1997). The essential components of caveolae are
caveolins that can form large oligomers bound to choles-
terols as demonstrated for VIP21/caveolin-1 (Murata et
al., 1995). De novo formation of caveolae, upon expres-
sion of VIP21/caveolin-1 (Fra et al., 1995) suggests that ca-
veolins regulate the dynamics of rafts. But, with the excep-
tion of caveolins, proteins modulating raft assembly await
to be identified.
After being released from the TGN, basolateral carriers
move along microtubules to the basolateral surface (La-
font et al., 1994) where they dock and fuse using the ubiq-
uitous soluble SNARE (
 
N-
 
ethyl maleimide-sensitive fac-
tor [NSF] attachment protein [SNAP]) receptors-Rab
machinery (Ikonen et al., 1995, for review see Rothman,
1994). In the apical pathway, apical carriers move along
microtubules to the apical surface (Lafont and Simons,
1996). After having crossed the subcortical network of ac-
tin cytoskeleton (Ojakian and Schwimmer, 1988; Fath and
Burgess, 1993; Muallem et al., 1995), the apical carriers
dock and fuse with the cell surface by a mechanism re-
maining to be clarified. Evidence for the involvement of
SNAREs in the apical membrane trafficking has been pro-
vided from cells overexpressing syntaxin-3 or from perme-
abilized cells with recombinant proteins and antibodies di-
rected against NSF added (Low et al., 1998; F. Lafont and
K. Simons, unpublished results). So far, the apical pathway
differs from the basolateral route by the lack of a require-
ment for NSF (Ikonen et al., 1995; Low et al., 1998).
Annexins belong to a family of proteins that has been
implicated in regulating membrane trafficking in exocyto-
sis and endocytosis where the annexins could be involved
in membrane-membrane interactions (Creutz, 1992; Moss,
1992; Gruenberg and Emans, 1993; Burgoyne and Clague,
1994; Raynal and Pollard, 1994). Such a role is supported
by their calcium-dependent binding to phospholipids due
to their endonexin fold repeats forming the annexin core
domain. We previously identified a protein in immunoiso-
lated apical carriers that turned out to be a new member of
the annexin family, namely annexin XIIIb (Fiedler et al.,
1995). Annexin XIIIb is the only annexin found in immu-
noisolated apical exocytic carriers (Wandinger-Ness et al.,
1990) and is an isoform of annexin XIIIa previously de-
scribed in human intestinal cells (Wice and Gordon, 1992).
It is worth mentioning that annexin XIIIs are the only an-
nexins myristoylated in their NH
 
2
 
-terminal part that is the
divergent domain among the members of the annexin fam-
ily. Immunofluorescence experiments showed that an-
nexin XIIIb is located in the apical compartment of
MDCK cells (Fiedler et al., 1995). An antibody raised
against annexin XIIIb inhibited the apical delivery of ve-
sicular carriers when introduced in streptolysin-
 
O
 
 (SLO)-
permeabilized cells (Fiedler et al., 1995). The interpreta-
tion of these results led us to speculate that annexin XIIIb
is involved in apical delivery. In this study, using the anti-
annexin XIIIb antibody and recombinant annexin XIIIb,
we provide morphological and functional evidence for a
direct role of annexin XIIIb in apical transport. Our re-
sults suggest that annexin XIIIb binds to apical rafts that
bud off the TGN and acts both at the TGN level and at the
cell surface.
 
Materials and Methods
 
Media and reagents for cell culture were purchased from GIBCO Biocult
(Eggestein, Germany).
 
 
 
Transwell™ polycarbonate filters (0.4-
 
m
 
m pore
size) for cell culture were from Costar (Cambridge, MA). Propidium io-
dide was from Molecular Probes (Eugene, OR). Restriction endonu-
cleases were from New England Biolabs (Schwalbach/Taunus, Germany),
polymerases from Boehringer Mannheim (Mannheim, Germany) and
DNA modifying enzymes from USB (Cleveland, OH). Unless otherwise
indicated chemicals were from Sigma (Deisenhofen, Germany). Mono-
clonal anti-annexin II antibody (HH7) was kindly provided by V. Gerke
(University of Münster, Münster, Germany). Affinity-purified rabbit anti–
vesicular stomatitis virus (VSV) G and anti-Rab 5 antibodies were pro-
vided by T. Nilsson and M. Zerial (EMBL, Heidelberg, Germany) respec-
tively. Polyclonal and monoclonal anti-hemagglutinin (HA) antibodies
were prepared as described (Gerhard et al., 1981 and Matlin et al., 1981,
respectively). Polyclonal anti-caveolin 1 antibody was purchased from 
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Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) or from Transduction
Laboratories, Inc. (Lexington, KY). Polyclonal anti-annexin-V antibody
was from Alexis Corp. (San Diego, CA). Monoclonal anti-TfR antibody
was from Zymed (Bad Homburg, Germany). Monoclonal anti-FLAG M2
antibody was from Kodak (New Haven, CT). Goat anti-rabbit HRP-con-
jugated and goat anti–mouse HRP-conjugated antibodies were from Bio-
Rad (München, Germany). Goat anti–rabbit FITC-conjugated antibody
was from Dianova (Hamburg, Germany). Protein A-coupled gold parti-
cles were purchased from the Department of Cell Biology, Faculty of
Medicine, Utrecht, Netherlands.
 
Cell Culture and Virus Stocks
 
MDCK cells, strain II of low resistance, were cultured on Transwell™ fil-
ters (Pimplikar et al., 1994). For immunocytochemistry purposes, cells
were seeded on 1.2-cm diameter filters with plating on 2.5 
 
3 
 
10
 
5
 
 cells per
filter. For biochemical experiments, cells were plated on 2.4- and 7.5-cm
diameter Transwell™ filters at a cell density of 10
 
6
 
 and 2.5 
 
3 
 
10
 
6
 
 cells per
filter, respectively, treated or not with mevalonate and lovastatin.
Stock of phenotypically mixed VSV (Indiana strain) grown in Chinese
hamster ovary C15.CF1 cells which express HA on their plasma mem-
brane and influenza stocks of N (A/chck/germany/49/Hav2Neq1) and PR8
(A/PR8/8/34) virus were prepared as described (Bennett et al., 1988; Mat-
lin and Simons, 1983).
 
Immunofluorescence Staining and Confocal Analysis
 
Fixation, quenching, permeabilization, denaturation, blocking, and all the
washing steps were performed at room temperature and with shaking of
the filters as before (Fiedler et al., 1995). The affinity-purified rabbit anti–
annexin XIIIb antibody was used diluted 1:10 (or 1:200 in experiments
where unmyristoylated recombinant annexin XIIIb was added to perme-
abilized cells) for overnight incubation at 4
 
8
 
C. DNA was stained with pro-
pidium iodide (0.05 
 
m
 
g/ml) for 15 min at 37
 
8
 
C in PBS as described (Lafont
et al., 1994). Cells were placed in mounting medium in PBS-glycerol
(Merck, Darmstadt, Germany) 1:1 with 0.1% NaN
 
3 
 
and 100 mg/ml
DABCO [1,4-diazabicyclo-2.2.2-octane]. Coverslips were perched on thin
bridges cut from cellophane and sealed with nail polish.
Cells were observed using a LSM 410 Confocal equipped with an Axio-
vert 100 microscope (Carl Zeiss, Oberkochen, Germany). Images were
processed using Adobe Photoshop™ Software (version 3.0.5; Mountain
View, CA) and further with Canvas™ software (version 3.5.4; Deneba
software, Miami, FL) on a Power MacIntosh™ computer (Apple, Cuper-
tino, CA).
 
TGN-derived Carriers Isolation
 
Infected MDCK cells plated on 7.5-cm filters for 3.5 d were perforated by
ripping off the apical plasma membrane with a nitrocellulose filter (Huber
and Simons, 1994) with the following modifications. Proteins from the
apical plasma membrane were biotinylated to allow, later on, their elimi-
nation by adsorbtion on immobilized streptavidin. To this aim, before per-
foration, cells were incubated 30 min at 4
 
8
 
C with 1 mg/ml Sulfo-NHS-LC-
Biotin (Pierce, Rockford, IL) in PBS containing 0.9 mM CaCl
 
2
 
 and 0.5
mM MgCl
 
2
 
. Three 5-min washes with glycine 0.1 M and BSA 0.5% in PBS
containing 0.9 mM CaCl
 
2
 
 and 0.5 mM MgCl
 
2 
 
were used to quench the
cross-linking reaction. After perforation, cells were incubated for 15 min
at 37
 
8
 
C in 500 
 
m
 
l of transport medium with a free calcium concentration
fixed at 100 nM with Hepes/EGTA and Hepes/CaCO
 
3
 
 buffers according
to concentrations calculated by the Max Chelator version 4.12 software
(1990) from C. Patton (Stanford University, CA). The medium was then
collected and adjusted to 30% Optiprep™ (Nycomed Pharma As, Oslo,
Norway) in 600 
 
m
 
l before being overlaid with 1.1 ml of 25% Optiprep™
and 400 
 
m
 
l of 10% Optiprep™ prepared in transport medium. Exocytic
carriers were floated for 2 h at 55,000 rpm in a TLS 55 Beckman rotor at
4
 
8
 
C. 200 
 
m
 
l of the interface between the 25% and 10% Optiprep™ steps
was collected and incubated 30 min at 4
 
8
 
C with 50 
 
m
 
l of a slurry (1:1) of
immunopure immobilized streptavidin (Pierce, Rockford, IL) in 25% Op-
tiprep™ prepared in transport medium. The carriers were obtained in the
supernatant after spinning the sample in a microfuge at 5,000 rpm 5 min at
4
 
8
 
C. Exocytic carriers were pelleted on a 2.0 M sucrose cushion at 30,000
rpm in a TLA 45 rotor and were processed for immunolabeling before
electron microscopy analysis.
 
Electron Microscopy
 
For single immunolabeling, untransfected and non-infected polarized
MDCK cells were used. For double immunolabeling, polarized MDCK
cells expressing VSV G-tagged sialyltransferase were infected with influ-
enza virus (Lafont et al., 1995). To this aim, human sialyltransferase
cDNA tagged with the VSV G-epitope in pSR
 
a
 
 vector (DNAX, Palo
Alto, CA; Rabouille et al., 1995) was electroporated into MDCK cells that
were grown under G418 selection for 2 weeks before selecting stably ex-
pressing clones. Single immunolabeling was done as described (Scheiffele
et al., 1998) with affinity-purified anti-annexin XIIIb antibody diluted 1:5
to 1:25. For double labeling, the grids were incubated with affinity-puri-
fied rabbit anti-VSV G or monoclonal anti-HA antibodies, washed and in-
cubated with protein A coupled 6- or 15-nm gold particles and further
processed as for single labeling.
For immunolabeling of isolated TGN-derived carriers, see Scheiffele et
al. (1998). Controls included the omission (or combinations) of primary
antibodies after which the accompanying gold particles were not detected.
For double immunolabeling performed on basolaterally SLO-perme-
abilized cells expressing the VSV G epitope-tagged sialyltransferase, ul-
trathin cryosections were obtained and processed for immunostaining as
described above using affinity-purified rabbit anti-VSV G and anti-annexin
XIIIb antibodies.
Labeled ultrathin cryosections were examined under a Zeiss transmis-
sion 10 C electron microscope (Zeiss, Oberkochen, Germany).
 
Expression and Purification of Unmyristoylated and 
Myristoylated Recombinant Annexin XIIIb
 
The outer primers 5
 
9
 
-AATGGATCCAAAATGGGCAATCGTCAT-
AGC-3
 
9
 
 and 5
 
9
 
-AAAATGCATTCAGTGCAAGAGGGCCAC-3
 
9
 
 were
used for PCR amplification of the annexin XIIIb cDNA template in the
Bluescript SK II plasmid (Fiedler et al., 1995). An insert fragment was ob-
tained after BamHI and NsiI (blunt) digestions. The insert was cloned in
the BamHI-SmaI digested pGAT2 expression vector. This vector contains
a modified T7
 
lac
 
 promoter and a fusion partner consisting of his6-glu-
tathione-
 
S
 
-transferase (his6-GST) gene linked with a thrombin cleavage
site in 5
 
9
 
 of the cDNA coding for annexin XIIIb (Peränen et al., 1996).
JM109(DE3) cells (Promega, Madison, WI) harboring pGAT2-AnxXIIIB
were cultured at 37
 
8
 
C in 2 liters of Luria broth medium with ampicillin
(100 
 
m
 
g/ml). Expression was induced by addition of isopropylthio-
 
b
 
-D-galac-
toside to 0.5 mM at an OD
 
600
 
 of 0.5 for 4 h. The cells were harvested and
pelleted at 4
 
8
 
C. Cells were resuspended in 30 ml of Buffer A (10 mM Tris-
HCl, pH 7.5, 1% Triton X-100, 1 mM EDTA, 0.5 mM Pefabloc [Boeh-
ringer Mannheim, Mannheim, Germany], and 0.5 mg/ml lysozyme) and
incubated for 30 min on ice. Cells were lysed with a French press (two
times at 800 PSIG) in buffer A. After addition of 300 mM NaCl and 5 mM
DTT, cell debris was removed by a 30-min spin at 18,000 rpm in a SW27
rotor at 4
 
8
 
C. The supernatant was filtered through a 0.45-
 
m
 
m pore Millex
filter (Millipore, France) and loaded onto glutathione columns prepared
as follows. Three columns were cast each with 2 ml slurry of glutathione
Sepharose 4B (Pharmacia, Uppsala, Sweden) washed once with 10 ml
PBS then equilibrated with 10 ml Buffer B (10 mM Tris, pH 7.5, 300 mM
NaCl, and 1 mM EDTA). 8 ml of lysate was loaded per column and incu-
bated in the cold room on a rotating wheel for overnight binding of the re-
combinant annexin XIIIb-GST to the glutathione. The columns were
washed each with 50 ml Buffer B and the protein was eluted with 3 ml
Buffer C (10 mM Tris, pH 7.5, 300 mM NaCl, 1 mM EDTA, 1 mM DTT,
0.5 mM Pefabloc, and 20 mM reduced glutathione). The eluted annexin
XIIIb-GST was then dialyzed overnight in the cold room in Buffer D (10
mM Tris, pH 7.5, 50 mM NaCl, and 1 mM EDTA) and cleavage between
annexin XIIIb and GST was achieved during dialysis upon incubation of
the sample with 0.5 mg/ml of thrombin. Resolution of annexin XIIIb from
the GST was subsequently obtained by loading the sample onto an anionic
exchange Mono-Q HR 5/5 column (Pharmacia). 2 ml of the samples were
loaded for each run and eluted with a salt gradient of 15 ml made with
Buffer D and Buffer E (10 mM Tris, pH 7.5, and 300 mM NaCl). The sep-
arated cleaved products were collected in 0.3-ml fractions at a flow rate of
1 ml/min. Annexin XIIIb was eluted at 210 mM NaCl, and the uncleaved
product, if any, was eluted at 240 mM NaCl. The purity of the fractions
was tested after separation on 12% reducing SDS–polyacrylamide gel us-
ing either colloidal blue or silver staining kits from Novex (San Diego,
CA). Fractions of pure protein were stored at 
 
2
 
20
 
8
 
C with 10 mM DTT.
The protein was dialyzed against KOAc buffer before being used in the in
vitro transport or budding assays. The yield was routinely 5 mg of pure 
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protein per liter of bacteria. We checked that the unmyristoylated recom-
binant protein was able to bind in a calcium-dependent manner liposomes
made from lyophilized brain extract containing 80–85% phosphati-
dylserine.
To obtain regulated production at a high level of myristoylated recom-
binant annexin XIIIb, the protein was expressed in 
 
Drosophila
 
 Schneider
(SL3) cells. For that purpose, the annexin XIIIb sequence was amplified
by PCR to obtain an EcoRI-KpnI fragment containing 29 nucleotides be-
fore the ATG and all the sequence of the gene except the stop codon. The
primers used for this amplification were: 5
 
9
 
-TCG GAA TTC TAC AGA
ACA ACT GTC T-3
 
9
 
 and 5
 
9
 
-C GAC GGT ACC GTG CAA GAG GGC
CAC-3
 
9
 
. The sequence has not been further modified because the Kozak
sequence of annexin XIIIb is very close to the consensus Kozak sequence
of 
 
Drosophila melanogaster
 
. The annexin XIIIb fragment has been in-
serted between the EcoRI-KpnI sites in the polylinker of a modified
pRmHa-3 vector provided by Dr. Jürgen Benting (EMBL, Heidelberg,
Germany). In brief, this vector contains, like the parental one, the copper
inducible 
 
Drosophila
 
 Metallothionein promoter in 5
 
9
 
 of the polylinker:
EcoRI-SacI-NheI-KpnI-SmaI-BamHI-ClaI-Flag tag-EcoRV-10xHis-SalI,
the KpnI and BamHI sites being in frame with the different tags. These
tags can be cleaved off by numerous proteases after purification of the
protein. Cotransfection of SL3 cells with pRmHa-3/AnxXIIIb and pUCh-
sneo was done according to (Jackson et al., 1992; Wallny et al., 1995) with
the modification that cells were cultured in presence of 1% FCS. The in-
duction of the protein was achieved by incubating the cells for 72 h with 2
mM CuSO
 
4
 
. The routine volume was 600 ml which gave rise to 2 g of dry
cells. After extensive washing, the cells were lysed (6 ml lysis buffer/g of
dry cells) at 37
 
8
 
C for 30 min in PBS, 150 mM NaCl, 1.5% Triton X-100, 10
mM imidazole, and a cocktail of protease inhibitors (CLAP: chymostatin,
leupeptin, antipain, pepstatin A; final concentration 25 mg/ml of each).
The supernatant of a 20-min spin at 4,000 
 
g
 
 was incubated overnight with
equilibrated Ni-NTA Agarose beads (Qiagen, Hilden, Germany). The
beads were then washed with increasing amount of imidazole in PBS, 150
mM NaCl, 1% Triton X-100. The last washes were performed without Tri-
ton X-100. The elution was obtained at 120 mM imidazole in PBS, 150
mM NaCl, 10 mM DTT, and CLAP. For the functional assays (see below),
the protein was concentrated through using a 10 filter (Amicon, Beverly,
MA) and dialyzed against KOAc buffer. We checked that the myristoy-
lated recombinant protein was able to bind liposomes. To select the clones
of Schneider cells expressing the highest amount of myristoylated annexin
XIIIb, 1 ml of each clone was induced with 1 mM CuSO
 
4
 
 for 24 h and 20 
 
m
 
l
[9.10(n)-
 
3
 
H] myristic acid (in ethanol solution at 1.89 TBq/mmol with 37
MBq/ml; Amersham, Braunschweig, Germany) was incorporated for the
last 20 h of culture. Cells were then washed three times in ice-cold PBS
and then lysed in PBS, 1% NP40, 1 mM DTT, and CLAP, for 30 min at
room temperature with shaking. The solubilized material was analyzed by
SDS-PAGE, gels were fixed and the signal was intensified (Intensify™;
Du pont de Nemours, Brussels, Belgium), and exposed for 2 wk.
 
Lovastatin/Mevalonate Treatment, Me
 
b
 
CD, and Triton 
Extractions, Floatation
 
We followed a procedure based on the inhibition of de novo synthesis of
cholesterol by lovastatin in the presence of mevalonate (used for the syn-
thesis of nonsterol products) and extraction of cholesterol from the
plasma membrane by Me
 
b
 
CD (Keller and Simons, 1998). When this pro-
cedure was used for MDCK cells grown on filters, cholesterol depletion
 
,
 
70% was accomplished (Keller and Simons, 1998). Control and Me
 
b
 
CD
extracted cells were rinsed by dipping in ice-cold PBS containing 0.9 mM
CaCl
 
2
 
 and 0.5 mM MgCl
 
2
 
 before they were transferred for 75 min to 20
 
8
 
C
with 3 ml on both sides of infection medium containing 0.35 g/liter sodium
bicarbonate. Then, filters were transferred to 37
 
8
 
C for 30 min. Cells were
cooled down by dipping the filters in 10 mM ice-cold Hepes, pH 7.4 and 2
mM EGTA. Cells were scraped with a rubber policeman in this buffer
containing 0.25 mM sucrose (United States Biochemical Corp., Cleveland,
OH), 5 mM DTT, and CLAP. Cells were homogenized by 25 passages
through a 25-G needle. For some floatation experiments cells were treated
with 100 
 
m
 
M latrunculin B (Calbiochem, Bad Soden, Germany) and 33
 
m
 
M nocodazole for 20 min at 37
 
8
 
C followed by 20 min on ice for complete
disruption of the cytoskeleton. For Triton extraction, samples were incu-
bated 30 min at 4
 
8
 
C with 1% (wt/vol) Triton X-100 (Serva, Heidelberg,
Germany). Samples were then either centrifuged at 120,000 
 
g
 
 for 30 min at
4
 
8
 
C on a 2 M sucrose cushion or submitted to floatation using OptiPrep™.
In this latter case, samples were made in 900 
 
m
 
l 1.077 g/ml with Op-
tiPrep™ and overlaid with a step gradient of 1.067, 1.043, and 1.037 g/ml
(1,350, 900, and 900 
 
m
 
l, respectively) using a mix of 0.25 M sucrose and
30% OptiPrep™ both in 10 mM Hepes, pH 7.4, 2 mM EGTA, and 1% Tri-
ton X-100. Floatation was performed in SW 60 Beckman tubes at 40,000
rpm for 18 h at 4
 
8
 
C. Nine fractions were collected and proteins were meth-
anol-chloroform precipitated for further analysis. Supernatants obtained
after the 120,000 
 
g
 
 centrifugation were methanol-chloroform precipitated.
The association of annexin XIIIb with rafts on TGN-derived vesicles
was determined using exocytic carriers collected from control or meval-
onate and lovastatin treated cells. These latter cells were further treated
with Me
 
b
 
CD 10 mM for 30 min at 37
 
8
 
C before the 1% Triton X-100 ex-
traction. Control and Me
 
b
 
CD-treated cells were Triton-extracted for 30
min at 4
 
8
 
C. Samples were made 1.159 g/ml using 200 
 
m
 
l of 10 mM ice-cold
Hepes, pH 7.4, 60% OptiPrep™, 1% Triton X-100 buffer adjusted with
Hepes/EGTA and Hepes/CaCO
 
3
 
 buffers such that the free calcium con-
centration was 100 nM. The sample was then overlaid with 1.130 g/ml (750
 
m
 
l), 1.180 g/ml (750 
 
m
 
l), and 1.052 g/ml (250 
 
m
 
l) prepared using the same
buffer. After 2 h spinning at 55,000 rpm in TLS 55 Beckman tubes at 4
 
8
 
C,
nine fractions (250 
 
m
 
l) were collected from the top. Proteins were metha-
nol-chloroform precipitated and analyzed by SDS-PAGE and Western
blotting using 5% nonfat dried milk, 0.1% Tween 20 in PBS as blocking
and incubation buffer.
 
In Vitro Cell Surface Transport Assay
 
This assay is performed on fully polarized SLO-permeabilized MDCK
cells and is energy, cytosol, and temperature dependent (Lafont et al.,
1995). The assay was carried out according to Pimplikar et al. (1994) with
the following modifications. Both myristoylated and unmyristoylated re-
combinant annexin XIIIb and the annexin II–p11 heterotetramer complex
were dialyzed against KOAc buffer (pH 7.4) before mixing with exoge-
nous cytosol and CLAP. In all cases, the free calcium concentration was
clamped to 100 nM with Hepes/EGTA and Hepes/CaCO
 
3
 
 buffers. After
the transport, the cells were lysed, proteins were separated by SDS-PAGE
(10% resolving gel), and band intensities were quantitated using Phosphor-
Imager™ and ImageQuant software™ (Molecular Dynamics, Sunnyvale,
CA). Calculations of transport efficiencies were done according to Pim-
plikar et al. (1994). Experiments were performed using duplicate filters
and SEM of at least three independent experiments are reported. The val-
ues are expressed as control cytosol-dependent transport being 100%
(transport in the presence of cytosol minus transport in the absence of
added cytosol).
 
Exocytic Carriers Budding from Semi-intact Cells
 
Release of HA and VSV G transport carriers from the TGN of semi-intact
cells grown on 10-cm dishes (Nunclon™; Nalge Nunc Int., Denmark) was
studied according to published procedures (Müsch et al., 1996; Scheiffele
et al., 1998). The budded fraction was obtained using a hypotonic swelling
procedure (Xu and Shields, 1993) to selectively disrupt the plasma mem-
brane (Beckers et al., 1987). The budding reaction was performed in pre-
lubricated microcentrifuge tube from Costar (Corning Costar Corpora-
tion, Cambridge, MA) in order to avoid any binding of vesicles to the wall
of the tube. The amount of HA or VSV G released in the budded vesicles
from the pool associated with TGN were quantitated using PhosphorIm-
ager™ and ImageQuant software™ (Molecular Dynamics, Sunnyvale,
CA). The values are expressed as control cytosol-dependent transport be-
ing 100% (transport in the presence of cytosol minus transport in the ab-
sence of added cytosol) and SEM of at least three independent experi-
ments are reported.
 
Results
 
Annexin XIIIb Localization during Polarization
 
We have previously shown that in fully polarized MDCK
cells, annexin XIIIb is located in the apical compartment
(Fiedler et al., 1995; Fig. 1 
 
A
 
). In nonconfluent MDCK
cells grown on coverslips, annexin XIIIb displays a punc-
tate staining uniformly distributed over the cytoplasm
(Fiedler et al., 1995). Here, we analyzed the distribution of
annexin XIIIb during the development of polarity in filter-
plated cells. We examined cells fixed after 24 h in culture 
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(Fig. 1 
 
B
 
) before they are functionally polarized according
to transepithelial resistance measurements and the local-
ization of surface antigens (Balcarova-Ständer and Si-
mons, 1984). At this stage, a mosaic of annexin XIIIb dis-
tribution was seen. In many cells annexin XIIIb was not
polarized. Nevertheless, in some cells annexin XIIIb was
already apically enriched (compare cells labeled with ar-
rows in Fig. 1 
 
B
 
 with those in Fig. 1 
 
A
 
). For comparison,
we analyzed the distribution of annexin II, which was uni-
formly distributed over the cells (Fig. 1 
 
C
 
). Therefore, the
polarization of annexin XIIIb is an early event.
 
Annexin XIIIb Distributes Along the Apical Route in 
Fully Polarized Cells
 
When analyzed in the confocal optical microscope, an-
nexin XIIIb accumulated at the apex of fully polarized
cells with a weak though significant intracellular staining
(Fig. 1 
 
A
 
). To determine precisely the subcellular distribu-
tion of annexin XIIIb, we performed immunoelectron mi-
croscopy.
Annexin XIIIb was found associated with tubulovesicu-
lar structures nearby the Golgi stack, with vesicular struc-
tures (diameter ranging from 50 to 100 nm) and with the
apical surface (Figs. 2 and 3 
 
A
 
–
 
C
 
). We quantified in cryo-
sections the percentage of gold particles found in either
the apical cytoplasmic region or the basolateral cytoplas-
mic region (Table I). Separately, we counted the gold par-
ticles within a region 50 nm from the apical, lateral or ba-
solateral membrane. In 7 cells analyzed, we counted 178 
 
6
 
21 gold particles/cell cryosection located within the apical
region, either membrane-associated or cytoplasmic (see
Fig. 2), while 54 
 
6 
 
13 gold particles/cell cryosection were
counted in the basolateral region. This result indicated
that 
 
z
 
77% of annexin XIIIb is apically distributed. More-
over, in the apical region, we detected 42 
 
6 
 
18 gold parti-
cles/cell cryosection directly associated with the plasma
membrane which represents 24% of gold particles within
the area above the cell nucleus. Only 6.5% of the gold par-
Figure 1. Survey of annexin XIIIb during MDCK cell polariza-
tion. Filter-grown MDCK cells were immunostained with anti-
annexin XIIIb or anti-annexin II antibodies (green) and nuclei
were labeled with propidium iodide (red). Samples were viewed
by confocal microscopy. Confocal (x, z) scans are presented. (A)
Fully polarized cell processed for annexin XIIIb immunostaining.
(B and C) Cells fixed after 24 h in culture before immunolabeling
with the anti-annexin XIIIb (B) or anti-annexin II (C) antibodies.
Notice that some cells in B (arrows) display specific apical surface
labeling like that observed for the entire monolayer when the
cells are fully polarized (A, arrow). Bar, 10 mm.
Figure 2. Overview of the ultrastructural distribution of annexin
XIIIb in polarized MDCK cells. Polarized filter-grown MDCK
cells were processed for immunoelectron microscopy with the
anti-annexin XIIIb antibody. Arrowheads point out gold parti-
cles in the cytoplasm distributed in close vicinity of membranes.
Bar, 400 nm.The Journal of Cell Biology, Volume 142, 1998 1418
ticles in the apical plasma membrane were located be-
tween the microvilli (Fig. 3, C1 and C2). Surface biotinyla-
tion followed by agarose-coupled streptavidin binding or
antibody binding at 48C on living cells, demonstrated that
annexin XIIIb was not accessible from the extracellular
compartment suggesting that it was exclusively localized
on the cytoplasmic side (data not shown). The Golgi stacks
were often observed lateral to the nucleus as typically
shown in Fig. 2. Therefore, of the 23% of annexin XIIIb
not found in the apical region a significant part is due to la-
beling associated with membranes in the vicinity of the
Golgi. On the other hand, annexin XIIIb was rarely ob-
served along the lateral or basal membranes; only 11% of
annexin XIIIb was found on the basolateral membrane
(Table I).
To confirm that annexin XIIIb was in the TGN, we in-
fected a cell line stably expressing an epitope-tagged sia-
lyltransferase with influenza virus. To accumulate the viral
glycoproteins in the TGN, we performed a 208C TGN
block for 75 min before fixing the cells. We found colocal-
ization of the TGN-resident enzyme sialyltransferase (Fig.
3 A, large gold) with annexin XIIIb (Fig. 3 A, small gold),
suggesting binding of annexin XIIIb to TGN membranes
(Fig. 3 A, inset). We quantitated the gold particles associ-
ated with annexin XIIIb on membrane structures cola-
beled for the sialyltransferase. We found a ratio 1.4 6 0.3:
8.3 6 1.3 (small gold particles associated with annexin XI-
IIb/large gold particles associated with sialyltransferase,
n 5 25). For comparison, we found only 0.4 6 0.1 small
gold on mitochondria (unspecific labeling, n 5 25). We
also observed immunodecorated vesicular profiles likely
to represent tubules or vesicles being released from the
TGN (Fig. 3 A). However, we did not detect significant en-
doplasmic reticulum, cis or medial Golgi immunostaining
(data not shown). When proteins were released from the
208C block, tubular and vesicular-like structures (diameter
ranging between 50 and 100 nm) displayed colocalization
of annexin XIIIb with the apical marker HA (Fig. 3, B1
and B2, annexin XIIIb small gold and HA large gold).
These structures could be localized rather distant from the
Golgi stacks (Fig. 3 B2), suggesting that they were TGN-
derived carriers. To strengthen this conclusion, we isolated
TGN-derived carriers from infected and perforated cells
(Fig. 4). Here, annexin XIIIb, HA and VIP21/caveolin-1
showed colocalization on the vesicles. Indeed, Table II
shows the quantitation derived from the observation of 40
carriers positive for HA (Fig. 4 A, 15 nm gold) and VIP21/
caveolin-1 (Fig. 4 A, 5 nm gold) that were labeled for an-
nexin XIIIb (Fig. 4 A, 10 nm gold). Using VSV infected
cells, we similarly quantified in table II the average num-
ber of 10-nm gold particles associated with annexin XIIIb
in 40 vesicles immunoreactive for both the basolateral
marker vesicular stomatitis virus glycoprotein (Fig. 4 B,
VSV G, 15 nm gold) and VIP21/caveolin-1 (Fig. 4 B, 5 nm
gold). We also checked whether some of the VSV G posi-
tive structures would represent endocytic elements by co-
labeling with anti-Rab 5 antibody. Our results showed that
Rab 5 positive structures contained very little annexin XI-
IIb (0.6 6 0.1 gold particle per VSV G and Rab 5 labeled
vesicles, n 5 50). This result indicated that when the baso-
lateral route is overstimulated upon VSV infection, only a
minor pool of annexin XIIIb could be detected on the ba-
Figure 3. Annexin XIIIb distributes along the apical pathway.
Double immunostaining was performed on influenza virus in-
fected polarized filter-grown MDCK cells expressing the VSV
G-tagged sialyltransferase before processing for electron micros-
copy. (A) Sialyltransferase detected with anti-VSV G antibody
(15 nm gold) and anti-annexin XIIIb (6 nm gold) labeling at the
Golgi level after a TGN block at 208C for 75 min. The inset illus-
trates colocalization of both sialyltransferase and annexin XIIIb
in the same vesicular profile found nearby the Golgi stacks. (B1
and B2) Examples of colocalization of annexin XIIIb (6 nm gold)
and HA (15 nm gold) in tubulovesicular structures. (C1 and C2).
Annexin XIIIb staining in tubulovesicular structures underneath
the apical surface (arrowheads) and in microvilli. Bars: (B1) 120
nm; (B2) 100 nm; and (C1 and C2) 120 nm.
Table I. Quantitative Distribution of Annexin XIIIb in 
Polarized MDCK Cells
Cytoplasmic
region
Number of gold particles/
cell cryosection
Plasma
membrane
Number of gold particles/
cell cryosection
Apical 178 6 21 Apical 42 6 18
Basolateral 54 6 13 Lateral 16 6 3
Basal 9 6 4
The table shows quantitation done on one cryosection per cell processed for immuno-
labeling with the anti-annexin XIIIb antibody and protein A-coupled 10-nm gold par-
ticles. Samples were examined under transmission electron microscopy as described
in Materials and Methods. Gold particles were counted in the cytoplasmic regions. For
either apical or basolateral cytoplasmic regions the number of gold particles associ-
ated with the plasma membranes (apical, lateral, or basal) is also indicated. Seven
cells were analyzed. Data are mean 6 SEM.Lafont et al. Annexins and the Apical Secretory Pathway 1419
solaterally routed carriers. Altogether these quantitations
indicated that annexin XIIIb was clearly enriched in the
apical HA-containing vesicles (more than threefold en-
richment, compare Table I with Table II). The weak an-
nexin XIIIb staining observed on these VSV G–containing
carriers might be due to a partial missorting caused by the
viral infection.
We conclude that annexin XIIIb is enriched in the apical
plasma membrane and in TGN-derived carriers en route
to the apical plasma membrane where annexin XIIIb colo-
calizes with HA.
Annexin XIIIb Is Associated with Apical Rafts
Next, we analyzed whether annexin XIIIb could be specif-
ically isolated in DIGs as has been shown for some other
apically routed proteins (Scheiffele et al., 1997; Keller and
Simons, 1998). Although annexins are known to bind
phospholipids in the presence of calcium, we previously
showed that annexin XIIIb had the unusual property of
binding to membranes in the absence of calcium (Fiedler
et al., 1995).
Indeed, in a typical experiment shown in Fig. 5 A, when
cells were homogenized in EGTA-containing buffer, an-
nexin XIIIb was clearly pelleted. After MebCD treatment
of lovastatin-mevalonate treated, annexin XIIIb also pel-
leted demonstrating that the MebCD treatment alone did
not lead to dramatic release of annexin XIIIb from mem-
branes (Fig. 5 A). Moreover, we checked that the overall
ultrastructure of the cells was not dramatically affected by
such treatment (data not shown), only caveolae on the ba-
solateral side were observed flattened in agreement with
previous data (Hailstones et al., 1998). After Triton X-100
Figure 4. Distribution of annexin XIIIb on exocytic TGN-derived
carriers. (A) Immunostaining of HA (15 nm gold), annexin XIIIb
(10 nm gold) and VIP21/caveolin-1 (5 nm gold) on TGN-derived
carriers obtained from cells whose apical membrane have been
ripped off (see Materials and Methods). (B) Immunostaining of
VSV G (15 nm gold), annexin XIIIb (10 nm gold) and VIP21/
caveolin-1 (5 nm gold) on TGN-derived carriers. Bar, 100 nm.
Note the enrichment of gold particles associated with annexin
XIIIb on HA-containing carriers versus the amount observed on
VSV G-containing carriers and see Table II. Bar, 100 nm.
Table II. Quantitative Analysis of Annexin XIIIb Distribution in 
Exocytic Vesicles from MDCK Cells
Annexin XIIIb VIP21/caveolin-1
HA
6.9 6 0.7 7.1 6 0.5 12 6 0.9
VSV G
4.4 6 0.3 2.0 6 0.4 8.7 6 0.7
Numbers of gold particles per vesicle are indicated. Gold label on 40 HA and 40 VSV
G positive vesicles from polarized cells was quantitated. Vesicles were considered
positive for the viral markers when they contained at least two gold particles. Data are
mean 6 SEM.
Figure 5. Annexin XIIIb is raft associated. Filter-grown MDCK
cells were infected with influenza virus. Cells treated with me-
valonate and lovastatin were extracted with MebCD. Then, cells
were submitted to a TGN block and chased at 378C before lysis.
(A) Lysed cells were either extracted with Triton X-100 or not
before centrifugation. Percentages of insoluble (P) and soluble
(S) annexin XIIIb were analyzed by Western blotting. Similar re-
sult were obtained in four independent experiments. (B) Lysed
cells were extracted with Triton X-100 and membranes were
floated in an OptiPrep™ step gradient. Western blotting was per-
formed on methanol-chloroform precipitated fractions. The first
two fractions correspond to the volume of the sample submitted
to floatation. (C) TGN-derived carriers from influenza virus in-
fected cells were extracted with Triton X-100 and membranes
were floated in an Optiprep™ step gradient. Western blotting
was performed on methanol-chloroform precipitated fractions.The Journal of Cell Biology, Volume 142, 1998 1420
extraction at 48C, a pool of annexin XIIIb remained insol-
uble although annexins are peripheral proteins that should
be efficiently solubilized by detergent extraction (Fig. 5
A). To differentiate whether annexin XIIIb was associated
with detergent-resistant membranes or with cytoskeletal
elements, we performed floatation experiments of Triton
X-100 extracts in sucrose-OptiPrep™ gradients in the ab-
sence of calcium (Fig. 5 B). We found that a pool of annexin
XIIIb floated to low densities, indicating that annexin
XIIIb was associated with detergent-resistant membranes
and that this association was calcium independent. To pre-
vent any association of annexin XIIIb with membranes via
binding to the actin cytoskeleton, we treated the cell lysate
with cytoskeleton-depolymerizing drugs but this treatment
did not change the overall floatation behavior. This floata-
tion experiment suggested that the association of annexin
XIIIb with DIGs containing influenza HA did not require
calcium.
As a more stringent test for raft association, we per-
formed floatation after depleting cells of cholesterol by
MebCD treatment. Less annexin XIIIb was observed in
the lightest density fractions after cholesterol depletion
(Fig. 5 B, MebCD) confirming that the floatation of an-
nexin XIIIb was dependent on the integrity of rafts. After
cholesterol depletion, floatation of HA was also reduced
consistent with previous data (Scheiffele et al., 1997). The
shift observed in the floatation pattern after cyclodextrin
treatment was reproducible (n 5 4). It is possible that
some of the annexin XIIIb associated with internal mem-
branes might not have been efficiently affected by the Me-
bCD treatment which was performed on intact cells (see
Keller and Simons, 1998).
As a control for a nonraft protein, we used the transfer-
rin receptor (TfR). This receptor is basolaterally targeted
in MDCK cells (Fuller and Simons, 1986) and is not in-
cluded in the DIGs (Kundu et al., 1996). This receptor was
not found in the light gradient fractions where annexin XI-
IIb and HA could be observed. We excluded that annexin
XIIIb associated in an unspecific manner with any deter-
gent-resistant membranes because it was not found in the
lightest buoyant fractions of the gradient that contained
membranes as judged by the presence of VIP21/caveolin-1
(Fig. 5 B). The difference observed in the floatation pat-
terns of annexin XIIIb and HA on one hand and VIP21/
caveolin-1 on the other hand could be explained by the
presence of VIP21/caveolin-1 on both apical carriers and
basolateral caveolae (Scheiffele et al., 1998) that would
have different densities. However, this interpretation re-
quires further studies.
Next, we determined whether annexin XIIIb was raft-
associated in TGN-derived carriers. Isolated TGN-derived
vesicles obtained from influenza virus-infected cells were
Triton-extracted on ice and subsequently subjected to
density gradient floatation. Annexin XIIIb was found as-
sociated with membranes floating in the gradient demon-
strating its presence in DIGs on TGN-derived vesicles
(Fig. 5 C). Furthermore, when cells were depleted of cho-
lesterol (using MebCD on mevalonate/lovastatin-treated
cells) before Triton extraction, significantly less annexin
XIIIb was associated with the floating membranes (Fig. 5 C).
Unmyristoylated and Myristoylated Recombinant 
Annexin XIIIb Affect Specifically the Apical Pathway
Previously we showed that a bivalent anti-annexin XIIIb
antibody was able to inhibit apical delivery of HA while
the VSV G delivery to the basolateral side was not af-
fected (Fiedler et al., 1995). Importantly, no endogenous
annexin XIIIb was leaking out of the cells after permeabi-
lization and the ratio between membrane-bound and cyto-
solic pool was identical in both control and permeabilized
cells (data not shown). Because of the localization of an-
nexin XIIIb at the apical plasma membrane, it was not
possible to exclude that apical carriers were blocked from
reaching the surface due to steric hindrance by the bound
antibody. Now, we checked whether addition of recombi-
nant protein had an effect on transport. The GST-fused
unmyristoylated recombinant annexin XIIIb expressed in
Escherichia coli (Fig. 6 A, lane 1) was purified on a glu-
tathione column (Fig. 6 A, lane 3) and after thrombin di-
gestion (Fig. 6 A, lane 4), the cleaved products were sepa-
rated by chromatography on a Mono-Q column. The
purified unmyristoylated recombinant annexin XIIIb (Fig.
6 A, lane 5) was then used in further experiments.
Figure 6. Purified unmyristoy-
lated recombinant annexin
XIIIb is efficiently reaching the
intracellular compartment in
permeabilized cells. (A) Purifi-
cation of recombinant annexin
XIIIb expressed in E. coli.
Lane  1,  E. coli lysate; lane 2,
last wash, and lane 3, elution
from glutathione column. Lane
4, Thrombin cleavage before
run on Mono-Q column. Lane
5, Purified recombinant annexin
XIIIb after Mono-Q column
elution. Lanes 1–4, Coomassie
blue staining. Lane 5, Silver staining. (B) Confocal (x,z) scans of cells either basolaterally (1, 2) or apically (3, 4) SLO-permeabilized.
Recombinant annexin XIIIb (1.2 mM) was added to samples 1 and 3. Nuclei were labeled with propidium iodide (red) and annexin
XIIIb and visualized using an anti-annexin XIIIb antibody (green). Note that the recombinant unmyristoylated protein is present in
both the apical and basolateral compartments (B1 and B3). Bar, 10 mm.Lafont et al. Annexins and the Apical Secretory Pathway 1421
We verified that exogenously added annexin XIIIb was
located inside the permeabilized cells by confocal analysis
on samples processed for immunocytochemistry with a
low concentration of anti-annexin XIIIb antibody that
shows only low signal for the endogenous protein. As
shown in Fig. 6, B1 and B3, in SLO-permeabilized MDCK
cells, the unmyristoylated recombinant annexin XIIIb was
distributing in both the apical and basolateral compart-
ments.
When the unmyristoylated recombinant annexin XIIIb
was tested in the transport assay, we found a dose-depen-
dent inhibition of apical delivery of HA (Fig. 7 A). Apical
transport could be inhibited ,80% with 1.2 mM of the un-
myristoylated recombinant protein. On the other hand,
transport of the VSV G protein was not impaired (Fig. 7
A). Importantly, even though the unmyristoylated recom-
binant annexin XIIIb was present in the entire cytoplasm
including the basolateral compartment (Fig. 6, B1 and B3)
it was only active in the apical pathway (Fig. 7 A). The lack
of effect on the basolateral pathway suggested a specific
role of annexin XIIIb in the apical route. To exclude a pos-
sible unspecific fusion event due to some functional prop-
erty common to annexins (i.e., unspecific membrane ag-
gregation), we analyzed whether the transport of HA
would be sensitive to another annexin located in the apical
compartment. We used the annexin II–p11 heterotet-
rameric complex. In fully polarized MDCK cells, we found
annexin II localized in the apical but also in the basolateral
compartment in agreement with previous result (Fig. 7 B;
Harder and Gerke, 1993). When we tested this protein oli-
gomer in the transport assay, we found no effect on apical
transport (Fig. 7 A). This result suggests that the inhibitory
effect observed with the recombinant annexin XIIIb was
not due to a functional property shared by several an-
nexins.
Since the endogenous annexin XIIIb is myristoylated,
we also tested the effect of the myristoylated form of the
recombinant protein. To obtain myristoylated recombi-
nant annexin XIIIb, the protein was expressed in E. coli
harboring a plasmid coding for the N-myristoylated trans-
ferase of S.cerevisiae (kindly provided by J. Gordon, St.
Louis, MO). However, the yield of myristoylated annexin
XIIIb was low but could be increased by expression in the
Drosophila Schneider SL3 cells which in contrast to the E.
coli possess endogenous N-myristoyl transferase activity.
The histidine-tagged myristoylated recombinant annexin
XIIIb (Fig. 8 A, lane 1) was purified on Ni-NTA beads
(see Materials and Methods; Fig. 8 A, lane 2). We also
checked that the selected clones were expressing the re-
combinant protein efficiently myristoylated (Fig. 8 A,
lanes  3 and 4). The purified myristoylated recombinant an-
nexin XIIIb was found to stimulate apical transport in a
dose-dependent manner whereas the basolateral route
was not affected by addition of the protein (Fig. 7 C).
Strikingly, when added from the basolateral side to SLO-
permeabilized cells, the myristoylated recombinant an-
nexin XIIIb was visualized after immunostaining mainly in
the apical compartment (Fig. 8 B) in contrast to the bacte-
rial protein that was located in both compartments (Fig. 6
B1). To determine more precisely the internal distribution
of the added myristoylated recombinant annexin XIIIb,
we performed immunoelectron labeling using an anti-Flag
antibody. As the endogenous protein, the myristoylated
recombinant annexin XIIIb was located at the apical sur-
face, on vesicular-like structures underneath the apical
plasma membrane and on internal membrane located in
the apical compartment (data not shown). It is important
to note that the effects induced by the recombinant pro-
Figure 7. Exocytic apical delivery is specifically sensitive to un-
myristoylated and myristoylated recombinant annexin XIIIb. (A)
Dose-dependent effect of unmyristoylated recombinant annexin
XIIIb (unmyr rec annexin XIIIb) expressed in E. coli in the in
vitro transport assay with HA and VSV G as reporter proteins
for the apical and basolateral exocytic pathway, respectively. An-
nexin II–p11 heterotetramer does not impair the apical transport
of HA. (B) Confocal (x, z) scan of polarized MDCK cells double
stained for nuclei (propidium iodide in red) and for annexin II
(green). (C) Dose-dependent effect of myristoylated recombinant
annexin XIIIb (myr rec annexin XIIIb) expressed in Drosophila
Schneider SL3 cells in the in vitro transport assay with HA and
VSV G as reporter proteins for the apical and basolateral exo-
cytic pathway, respectively. Bar, 20 mm.The Journal of Cell Biology, Volume 142, 1998 1422
teins in the transport assay were obtained with quantities
that were not dramatically different from the physiological
range. We estimated the amount of recombinant protein
added being 2.5 (myristoylated) or 3 times (unmyristoy-
lated) over the quantity of the endogenous annexin XIIIb
found in control permeabilized cells (data not shown).
Anti-Annexin XIIIb Inhibits the Formation of
HA-containing Carriers from the TGN
As myristoylated and unmyristoylated annexin XIIIb had
different effects on apical surface delivery, we wanted to
determine whether the added annexin XIIIb played a role
in the budding of apical carriers from the TGN. We used
an assay that allowed us to quantify the release in a cyto-
sol- and energy-dependent manner of TGN-derived carri-
ers containing either HA (apical carriers) or VSV G (ba-
solateral carriers; Müsch et al., 1996). We tested the effect
of the anti-annexin XIIIb antibody in this assay using an-
other polyclonal antibody as a matched control. Since an-
nexin V is located (though not exclusively) in the apical
compartment of MDCK cells (Fig. 9 A), we tested an anti-
Figure 8. Purified myristoylated recombinant annexin XIIIb is
reaching the apical compartment of MDCK cells. (A) Purifica-
tion of annexin XIIIb from Drosophila Schneider cells. Lane 1,
Coomassie blue staining of the total lysate. Lane 2, Silver staining
of eluted purified recombinant annexin XIIIb (see Materials and
Methods). Arrowheads indicate the myristoylated annexin XIIIb.
Note the appearance of dimers at 90 kD (each monomer is
formed by the fusion of annexin XIIIb and histidine plus FLAG
tags). Lanes 3–5, Autoradiography of annexin XIIIb expressing
clones (lanes 3 and 4 clones BM17 and BM18, respectively) and
of control cells (lane 5) after 3H-myristate labeling. (B) Distribu-
tion of the myristoylated recombinant annexin XIIIb in basolat-
erally SLO-permeabilized MDCK cells. The myristoylated re-
combinant protein was added from the basolateral side. Confocal
(x, z) scans of cells double stained for nuclei (propidium iodide in
red) and for the myristoylated recombinant annexin XIIIb with
the anti-Flag antibody (green). Note that although in some cases
the myristoylated recombinant protein was observed in both api-
cal and basolateral compartments, the recombinant protein was
mainly found in the apical compartment. Bar, 20 mm.
Figure 9. Effects of anti-annexin XIIIb antibody, unmyristoy-
lated and myristoylated recombinant annexin XIIIb on TGN-
derived carriers release. (A) Confocal (x, z) scans of polarized
MDCK cells double stained for nuclei (propidium iodide in red)
and annexin V (green). (B) Anti-annexin XIIIb antibody can in-
hibit the budding of HA-containing carriers while it is not inter-
fering with the budding of VSV G-containing carriers. Unmyris-
toylated recombinant annexin XIIIb (unmyr rec annexin XIIIb) is
not affecting the release from the TGN of HA- or VSV G-con-
taining carriers. The matched controls, i.e., anti-annexin V antibody
and the annexin II–p11 complex have no effect on the budding of
TGN-derived carriers (see text). (C) Myristoylated recombinant
annexin XIIIb (myr rec annexin XIIIb) can stimulate in a dose-
dependent manner the release of HA-containing carriers from
the TGN while leaving the release of VSV G-containing carriers
unaffected. Bar, 10 mm.Lafont et al. Annexins and the Apical Secretory Pathway 1423
annexin V in the budding assay and found that it did not
interfere with the release of TGN-derived carriers; we ob-
tained similar results with an anti-annexin VI antibody
and an anti-annexin II antibody (MC2 affinity-purified
rabbit and monoclonal HH7 antibodies, provided by S.E.
Moss [University College, London, UK] and V. Gerke
[University of Münster, Germany], respectively, data not
shown). In contrast, the anti-annexin XIIIb antibody in-
hibited budding of HA-containing vesicles whereas the
budding of the VSV G-containing vesicles was not im-
paired (Fig. 9 B). These results argue for a specific effect in-
duced by the anti-annexin XIIIb antibody. We then ana-
lyzed the effect of the myristoylated recombinant annexin
XIIIb on the budding assay using the annexin II–p11 het-
erotetramer as a control. While annexin II–p11 heterotet-
ramer had no effect on the release of TGN-derived vesi-
cles, myristoylated recombinant annexin XIIIb stimulated
the release of apical carriers in a dose-dependent manner
(Fig. 9 C). No effect of myristoylated recombinant annexin
XIIIb was seen on basolateral carriers. Addition of un-
myristoylated recombinant annexin XIIIb had no inhibi-
tory action on the budding of apical carriers (Fig. 9 B).
The unmyristoylated recombinant protein also did not af-
fect the release of the basolateral carriers (Fig. 9 B). We
also found an enrichment of the unmyristoylated recombi-
nant protein on the TGN in permeabilized cells as deter-
mined by quantitating the extent of membrane structures
colabeled with annexin XIIIb and the epitope-tagged si-
alyltransferase. We found that on the same membrane
structures 8.2 6 1.5 gold particles associated with sialyl-
transferase were colocalizing with 4.5 6 0.7 gold particles
associated with annexin XIIIb (n 5 25). The average
amount of annexin labeling associated with mitochondria
was of 0.5 6 0.2 (n 5 25) excluding that the added recom-
binant protein was unspecifically binding any cell mem-
brane. Thus, when compared with the quantitation per-
formed for the endogenous annexin XIIIb in intact cells
(see above), there was about three times more annexin
XIIIb bound to the TGN while the unspecific labeling re-
mained unchanged.
These findings lead us to suggest that annexin XIIIb reg-
ulates the formation and/or the budding of apical carriers
and that its action might extend to the docking and fusion
stage of apical delivery.
Discussion
In this study, we have demonstrated a specific role for an-
nexin XIIIb in the delivery of influenza virus HA from the
TGN to the apical surface. Several lines of evidence sup-
port this conclusion, namely the distribution of annexin
XIIIb, its association with apical rafts and the results from
functional assays.
Our subcellular localization data show that annexin XI-
IIb is uniquely placed to function in apical transport. In
fully polarized MDCK cells, annexin XIIIb is localized
along the route from the TGN to the apical plasma mem-
brane. In the TGN, annexin XIIIb colocalized with the
TGN resident enzyme sialyltransferase. In the apical cyto-
plasm, we could visualize annexin XIIIb on tubular or ve-
sicular structures devoid of sialyltransferase. These struc-
tures could be viewed as carriers en route from the TGN.
Supporting this interpretation, we observed that annexin
XIIIb colocalized with HA in tubulovesicular and vesicu-
lar-like structures both in cryosections of MDCK cells and
in isolated TGN-derived vesicles. This is in accordance
with our previous biochemical results using immunoiso-
lated apical transport vesicles (Wandinger-Ness et al.,
1990; Fiedler et al., 1995). The results presented here thus
extend these data by showing that annexin XIIIb colocal-
izes with HA in the same carrier. This vesicle fraction con-
tains several other proteins that in subsequent studies
were visualized in the apical compartment. However,
these proteins, namely vesicular integral proteins (VIPs)
of 17 kD, 21 kD (caveolin-1), and of 36 kD were also ob-
served in the basolateral compartment although most
likely associated in a different way as was recently shown
for VIP 21/caveolin-1 (Scheiffele et al., 1998). Therefore,
to date, among the proteins identified in immunoisolated
apical carriers, annexin XIIIb is the only protein together
with HA that has a predominantly apical distribution. An-
nexins are thought to mediate fusion events and several
annexins have previously been shown to localize in the
apical compartment of epithelial cells, i.e., annexins I, II,
IV, and VI. However, these annexins are absent from
immunoisolated apical vesicles (Wandinger-Ness et al.,
1990). Thus, the localization of annexin XIIIb places it as a
major candidate for a key role in the apical biosynthetic
route of MDCK cells.
A role for annexin XIIIb in apical transport was further
suggested by its association with apical rafts as shown by
the inclusion of annexin XIIIb in DIGs. We found an asso-
ciation of annexin XIIIb with rafts that was not calcium
dependent. This case is especially intriguing because an-
nexin XIIIb is a peripheral membrane protein associated
with the inner leaflet of the rafts. Our result raises the
question of how a cytosolic peripheral protein can associ-
ate with a lipid microdomain with cholesterol and sphin-
golipids enriched in the exoplasmic leaflet.
One feature could be the myristoylation of annexin XI-
IIb (Wice and Gordon, 1992; Lafont, F., unpublished re-
sults). Myristoylation is a cotranslational and irreversible
event that is found in many peripheral proteins partition-
ing between the cytosol and membranes (Johnson et al.,
1994; Boutin, 1997). Doubly acylated proteins like the Ga
subunit of heterotrimeric G proteins and the nonreceptor
protein kinases also share the property of being associated
with lipid rafts from the cytosolic side (Sargiacomo et al.,
1993). Furthermore, for both Ga and the src-like kinases,
double acylation by myristoylation and palmitoylation
seems to be required for their binding to DIGs (Brown
and London, 1997; Harder and Simons, 1997; Scheiffele
and Simons, 1998). As for annexin XIIIb, the kinase fyn
was shown to be increasingly solubilized after Triton ex-
traction upon removal of cholesterol by MebCD (Scheif-
fele et al., 1997).
However, the single acylation of annexin XIIIb is un-
likely to be sufficient for DIG-association. Interestingly,
other annexins (i.e., II, IV, V, and VI) have been shown to
associate with DIGs and these proteins are neither myris-
toylated nor palmitoylated (Sargiacomo et al., 1993;
Schnitzer et al., 1995; Parkin et al., 1996). A recent report
analyzed annexin II behavior after treating a membrane
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with cholesterol-sequestering drugs or digitonin in the ab-
sence of calcium (Harder et al., 1997). Annexin II was ex-
tracted together with a subset of proteins all related to the
actin cytoskeleton (ezrin, moesin, and a-actinin) that were
immunoprecipitated with an anti-annexin II antibody. The
interpretation of this result led the authors to conclude
that annexin II could serve as an interface between actin
and cholesterol-rich membrane domains. How annexin II
binds to DIGs is not known. Either the protein binds to
raft lipids or to raft proteins or to both. Altogether these
and our studies suggest that annexins II, IV, V, VI, and
XIII function in specific lipid environments and that they
can be floated with DIGs. How far this can be generalized
to the other members of the annexin superfamily and how
important this property is for their physiological role re-
mains to be elucidated.
Concerning annexin XIIIb, we combined cholesterol de-
pletion and floatation analysis after detergent solubiliza-
tion to demonstrate that annexin XIIIb binds to rafts. Al-
though from a total cell extract a small pool of annexin
XIIIb was observed floating after Triton extraction we
think that this finding is highly significant because the sol-
uble pool remains at the bottom of the gradient. We can
therefore exclude a smearing effect since annexin XIIIb
needs to bind membranes of light density to float. Annexin
XIIIb was not found associated with all membranes float-
ing since was not found in the very top fractions where a
pool of VIP21/caveolin-1 was recovered. The shift ob-
served after cholesterol extraction was reproducible and
was also observed when the same experiment was per-
formed with isolated apical carriers. The binding of an-
nexin XIIIb to membranes of the same buoyant density as
associated with HA did not depend on polymerized actin
as treatment of the samples with latrunculin did not abol-
ish DIG association. The binding to DIGs could be medi-
ated both by myristoylation on the NH2 terminus and by
the intrinsic lipid binding features of annexins such as
those involved in the binding of annexin II to DIGs. What
features of the inner lipid leaflet of sphingolipid-choles-
terol rafts could determine how annexins associate with
rafts? The main characteristic of annexins is their calcium-
dependent binding to negatively charged phospholipids
(Blackwood and Ernst, 1990). One interesting candidate is
phosphatidylinositol (4,5) biphosphate (PIP2) which has
been shown to be present in DIGs (Pike and Casey, 1996).
Annexins have been described either not to be able to
bind PIP2 when immobilized on hydrophobic support
(Edwards and Crumpton, 1991) or to bind PIP2 when in-
corporated in liposomes although without preference over
other charged phospholipids e.g., phosphatidic acid or
phosphatidyl serine (Junker and Creutz, 1994). Clearly,
analysis of the binding should be extended to lipid vesicles
mimicking raft microdomains. Another important issue
for future work is whether these interactions involve other
proteins associated with the lipid rafts such as for instance
VIP 21/caveolin-1. Annexin XIIIb and annexin II associ-
ate with DIGs that derive at least partially from different
cellular compartments because these two annexins do not
colocalize. This suggests that different annexins could be
associated with DIGs present in different compartments
and therefore raises the question of their function in dif-
ferent cellular locations. Annexins could regulate protein–
protein and protein–lipid interaction in membrane micro-
domains involved in sorting events and signal transduction
cascades. Different annexins could modulate raft function
by binding to sphingolipid-cholesterol rafts in different or-
ganelles.
The role of annexin XIIIb in apical transport receive
further support by our experiments with recombinant pro-
teins in the SLO-permeabilized cells. Recombinant an-
nexin XIIIb lacking its NH2-terminal myristoyl group was
shown to inhibit apical delivery while addition of myris-
toylated annexin XIIIb to the permeabilized cells stimu-
Figure 10. Model for the participation of annexin XIIIb and for
the role played by the recombinant proteins in the apical exocytic
pathway. (A) The raft-associated annexin XIIIb in the TGN level
promotes assembly of apical carriers and participates in the dock-
ing and/or fusion steps at the plasma membrane. The raft depicted
in red lines should be considered as membrane microdomains
whose lipids are enriched in sphingolipid and cholesterol. In the
last steps of exocytic transport annexin XIIIb could function ei-
ther by binding to a membrane receptor (lipid domain I and/or
proteins II), or by oligomerization (III). (B) Influence of un-
myristoylated (unmy rec) and myristoylated (myr rec) recombi-
nant annexin XIIIb on the apical exocytic pathway. The unmyris-
toylated protein inhibits the docking and/or fusion steps by
interfering with the binding of the endogenous annexin XIIIb to
its membrane ligand: lipid microdomains (I), protein complex, in-
cluding putative cytosolic proteins (II), or itself, oligomerization
(III). The myristoylated recombinant protein acts as the endoge-
nous protein and increases the efficiency of the apical transport.Lafont et al. Annexins and the Apical Secretory Pathway 1425
lated apical transport specifically. By analyzing the effects
of these recombinant proteins in an assay that measures
the release of apical and basolateral carriers from the
TGN (Müsch et al., 1996) the stimulatory action of myris-
toylated annexin XIIIb could be pinpointed to the stage of
the budding process. However, the unmyristoylated an-
nexin XIIIb did not affect the release of apical carriers.
Thus, the inhibition effect of this recombinant protein ob-
served on the apical delivery of TGN-derived carriers
must concern the delivery of the transport carriers or the
docking/fusion stage. We exclude a general annexin effect
of annexin XIIIb (i.e., general lipid-binding leading to ag-
gregation of vesicles inside the cells) because the annexin
II–p11 heterotetramer had no effect on apical transport al-
though this annexin is present in MDCK cells and local-
ized in the apical and basolateral compartments. We also
did not observe the formation of giant vesicles upon addi-
tion of recombinant unmyristoylated annexin XIIIb (data
not shown).
There are several mechanisms that could account for
how annexin XIIIb exerts its effect on apical transport.
Taking into account the dynamics of raft domains (Harder
and Simons, 1997a), one has to consider not only proteins
recruited into these rafts but also proteins involved in clus-
tering rafts into larger domains. In the TGN, annexin XI-
IIb could be involved in assembling raft lipids and proteins
into the apical carriers. One important issue is the topol-
ogy of the annexin XIIIb binding to the lipids. Annexin
molecules have been shown to possess a slightly curved
shape with the calcium and phospholipid binding domains
on the convex face and with the NH2- and COOH-termi-
nal domains on the concave face (Benz and Hofmann,
1997). If the NH2 terminus was associated with the lipid bi-
layer, would the calcium and phospholipid binding do-
mains be exposed to the cytosol (see Fig. 10 A)? In that
case, the membrane association of annexin XIIIb should
be weak since the unitary Gibbs free energy for binding a
myristoylated peptide to a phospholipid bilayer is not suf-
ficient for membrane anchorage (Peitzsch and McLaugh-
lin, 1993). Thus, other interactions would be required to
stabilize the binding to the lipid microdomains.
Another possibility is that annexin XIIIb is an adaptor
that leads to the binding of other molecules to the apical
transport carriers e.g., microtubule motors. Alternatively,
annexin XIIIb could be involved in opening the way for
the apical transport carriers through the cortical actin net-
work underlying the apical plasma membrane. Indeed, an-
nexin II has been proposed to mimic the effect on the cor-
tical actin network by 14-3-3 proteins that might explain its
effect on regulated exocytosis (Ali et al., 1989; Sarafian et
al., 1991; Graham et al., 1997). We cannot exclude that
annexin XIIIb would act in exocytosis by remodelling the
actin cytoskeleton. However, we think that a direct role on
the cytoskeleton is unlikely. We have not observed changes
in the actin network when the unmyristoylated recombi-
nant annexin XIIIb was introduced in permeabilized
MDCK cells (Lecat, S., unpublished data). Moreover, we
know that this recombinant protein does not bind actin
(Lecat, S., unpublished data).
Although evidence is emerging for a role of SNAREs in
the apical exocytic pathway, the sequence of events lead-
ing to the delivery is not understood. The relationship be-
tween SNAREs and annexins require further study. The
fact that annexin XIIIb is present both on apical carriers
and at the cytosolic surface of the apical plasma mem-
brane suggests that annexin XIIIb could be involved in the
docking/fusion stage of delivery of HA to the apical cell
surface (Fig. 10 A). In this way, annexin XIIIb could also
contribute to docking specificity. The flexibility of the
molecule allowing one monomer to link donor and accep-
tor membranes would facilitate bilayer docking (Fig. 10 A,
I) as has been proposed for other annexins e.g., (Ernst et
al., 1991). Alternatively, annexin XIIIb on the carrier sur-
face and on the cytoplasmic leaflet of the apical plasma
membrane would allow the formation of homooligomers
(Fig. 10 A, III), for instance by trimers on each side form-
ing bridging hexamers as suggested for annexin XII
(Luecke et al., 1995). Like many other annexins, recombi-
nant annexin XIIIb can form dimers (Fig. 8 A), trimers,
and hexamers (our unpublished data). Whether such oli-
gomers are formed in MDCK cells remains to be seen.
Identification of annexin XIIIb binding partners (see Fig.
10  A, II) will help to connect annexin XIIIb to the
SNARE docking and fusion machinery (Weber et al.,
1998) or possibly to define a novel mechanism for mem-
brane delivery.
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